JG
TEVA icon

Jefferies Group’s Teva Pharmaceuticals TEVA Stock Holding History

Jefferies Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-76,700
Closed -$740K – 1987
2020
Q4 		$740K Hold
76,700
– – 0.01% 1021
2020
Q3 		$691K Hold
76,700
– – 0.01% 908
2020
Q2 		$946 Hold
76,700
– – 0.01% 776
2020
Q1 		$689K Sell
76,700
-26,100
-25% -$267K 0.01% 1187
2019
Q4 		$1.01M Buy
+102,800
New +$918K 0.01% 1459
2019
Q3 		– Sell
-11,400
Closed -$105K – 3038
2019
Q2 		$105K Buy
+11,400
New +$137K ﹤0.01% 2272
2019
Q1 		– Sell
-81,000
Closed -$1.25M – 2625
2018
Q4 		$1.25M Sell
81,000
-12,500
-13% -$256K 0.01% 1051
2018
Q3 		$2.01M Buy
93,500
+22,800
+32% +$529K 0.01% 975
2018
Q2 		$1.72M Buy
+70,700
New +$1.44M 0.01% 975
2017
Q1 		– Sell
-440,400
Closed -$16M – 2649
2016
Q4 		$16M Sell
440,400
-136,700
-24% -$5.46M 0.09% 210
2016
Q3 		$26.6M Buy
577,100
+549,100
+1,961% +$28.6M 0.14% 119
2016
Q2 		$1.41M Buy
+28,000
New +$1.49M 0.01% 1019
2016
Q1 		– Sell
-76,100
Closed -$5M – 2549
2015
Q4 		$5M Sell
76,100
-196,000
-72% -$12.1M 0.03% 470
2015
Q3 		$15.4M Buy
272,100
+204,500
+303% +$13.3M 0.09% 168
2015
Q2 		$4M Sell
67,600
-648,500
-91% -$40M 0.02% 606
2015
Q1 		$44.6M Buy
716,100
+613,600
+599% +$35.7M 0.25% 56
2014
Q4 		$5.89M Buy
+102,500
New +$5.71M 0.03% 376
2014
Q2 		– Sell
-347,800
Closed -$18.4M – 2373
2014
Q1 		$18.4M Buy
347,800
+287,700
+479% +$13.3M 0.18% 100
2013
Q4 		$2.41M Buy
60,100
+43,200
+256% +$1.7M 0.02% 519
2013
Q3 		$638K Buy
+16,900
New +$659K 0.01% 1102

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Jefferies Group's TEVA Position: Q3 2022 in Review

Jefferies Group reduced its Teva Pharmaceuticals (TEVA) stake by 6.2% in Q3 2022, selling an estimated $150K and leaving 258,664 shares worth $2.09M. The position accounts for 0.02% of the portfolio, ranked #591.

Jefferies Group first reported a position in TEVA in Q3 2013 and has held it in 32 quarters since. The position peaked at $72.6M in Q1 2015. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Jefferies Group held 258,664 shares of Teva Pharmaceuticals worth $2.09M as of Q3 2022.
  • Jefferies Group sold 16,965 Teva Pharmaceuticals shares in Q3 2022, an estimated $150K.
  • Teva Pharmaceuticals made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #591 holding.
  • Jefferies Group first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 32 quarters since.
  • Jefferies Group's Teva Pharmaceuticals position peaked at $72.6M in Q1 2015.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.